Toward personalized medicine for age-related macular degeneration

American Journal of Ophthalmology

Volumn 154, Issue 3, 2012, Pages 427-428

  Souied, Eric H ^a   Leveziel, Nicolas ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; VASCULOTROPIN INHIBITOR;

BODY MASS; CORRELATION ANALYSIS; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HUMAN; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SMOKING; SUBRETINAL NEOVASCULARIZATION;

DELIVERY OF HEALTH CARE; GENETIC ASSOCIATION STUDIES; HUMANS; INDIVIDUALIZED MEDICINE; MACULAR DEGENERATION; PHARMACOGENETICS; PROTEINS;

EID: 84865809920     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2012.05.022     Document Type: Editorial

References (14)

1. E.H. Souied, P. Benlian, P. Amouyel The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration Am J Ophthalmol 125 3 1998 353 359
2. D.D. Despriet, C.C. Klaver, J.C. Witteman Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration JAMA 296 3 2006 301 309
3. J.M. Seddon, R. Reynolds, Y. Yu, M.J. Daly, B. Rosner Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors Ophthalmology 118 11 2011 2203 2211
4. N. Leveziel, J. Zerbib, F. Richard Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes Invest Ophthalmol Vis Sci 49 7 2008 3090 3094
5. K.P. Magnusson, S. Duan, H. Sigurdsson CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD PLoS Med 3 1 2006 e5
6. L. Sobrin, R. Reynolds, Y. Yu ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration Am J Ophthalmol 151 12 2011 345 352
7. B.J. Wegscheider, M. Weger, W. Renner Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration Ophthalmology 114 4 2007 738 742
8. N. Leveziel, N. Puche, F. Richard Genotypic influences on severity of exudative age-related macular degeneration Invest Ophthalmol Vis Sci 51 5 2010 2620 2625
9. M.T. Andreoli, M.A. Morrison, B.J. Kim Comprehensive analysis of complement factor H and LOC387715/ARMS2/HTRA1 variants with respect to phenotype in advanced age-related macular degeneration Am J Ophthalmol 148 6 2009 869 874
10. H. Tamura, A. Tsujikawa, K. Yamashiro Association of ARMS2 genotype with bilateral involvement of exudative age-related macular degeneration Am J Ophthalmol 154 3 2012 542 548
11. M.L. Klein, P.J. Francis, B. Rosner CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration Ophthalmology 115 6 2008 1019 1025
12. L. Ho, R. van Leeuwen, J.C. Witteman Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study Arch Ophthalmol 129 6 2011 758 766
13. B. Kloeckener-Gruissem, D. Barthelmes, S. Labs Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD Invest Ophthalmol Vis Sci 52 7 2011 4694 4702
14. A. Orlin, D. Hadley, W. Chang Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration Retina 32 1 2012 4 9